Related Experiment Video

Updated: May 13, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma

Dong Whan Lee1, Dhivya Ramakrishnan, John Valenta

  • 1Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas, United States of America.

Plos One
|March 2, 2013
PubMed

Insights

The NF-κB protein RelB drives aggressive mesenchymal glioma growth and invasion. Inhibiting this pathway offers a potential new therapy for glioblastomas, improving patient survival rates.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • High-grade gliomas, including glioblastomas (GBMs), are aggressive brain tumors with poor prognoses.
  • Distinct glioma subtypes are recognized, but the molecular drivers of tumorigenesis within each remain unclear.
  • Aberrant nuclear factor-kappa B (NF-κB) activity is implicated in glioma, yet specific family member roles are not fully understood.

Purpose of the Study:

  • To investigate the role of the NF-κB protein RelB in glioma pathogenesis, particularly within aggressive subtypes.
  • To determine if RelB influences glioma cell survival, motility, invasion, and tumor growth.
  • To assess the therapeutic potential of targeting the RelB-mediated pathway in mesenchymal gliomas.

Main Methods:

  • Analysis of RelB expression in glioma subtypes.
  • Functional studies involving RelB knockdown in glioma cells to assess effects on survival, motility, and invasion.
  • Gene expression analysis to identify RelB-regulated genes (e.g., YKL-40, Olig2).
  • In vivo studies using orthotopic mouse xenograft models.
  • Correlation analysis with human glioblastoma genome database.

Main Results:

  • RelB is expressed in aggressive mesenchymal glioma subtypes.
  • Loss of RelB significantly reduced glioma cell survival, motility, and invasion.
  • RelB promotes the expression of mesenchymal genes (YKL-40) and Olig2.
  • RelB deficiency diminished tumor growth in mouse models.
  • High RelB expression in human GBM correlates with rapid progression and poor survival.

Conclusions:

  • RelB acts as an oncogenic driver in mesenchymal glioma.
  • Targeting the noncanonical NF-κB (RelB-mediated) pathway presents a potential therapeutic strategy for aggressive gliomas.
  • Understanding RelB's role opens avenues for personalized glioblastoma therapies.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...